Related Experiment Video
Updated: Aug 9, 2026

Assessing Whole-Body Lipid-Handling Capacity in Mice
Published on: November 24, 2020
Strain-specific response to beta 3-adrenergic receptor agonist treatment of diet-induced obesity in mice
S Collins1, K W Daniel, A E Petro
1Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, North Carolina 27710, USA.
Abstract:
Fat intake has long been associated with the development of obesity. The studies described herein show that fat adversely affects adipocyte adrenergic receptor (AR) expression and function. As beta 3AR agonists have been shown to acutely reduce adipose tissue mass and improve thermogenesis in genetically obese rodents, we examined whether chronic supplementation of a high fat diet with a highly selective beta 3AR agonist, CL316,243 could prevent diet-induced obesity, and whether the effect could be sustained over prolonged treatment. C57BL/6J and A/J mice were weaned onto one of three diets: low fat (10.5% calories from fat), high fat (58% calories from fat), or high fat supplemented with 0.001% CL316,243. B/6J mice gained more weight on the high fat diet than A/J mice (at 16 weeks: B/6J, 36.6 +/- 1.4 g; A/J, 32.9 +/- 0.8 g; P < 0.002; n = 10), whereas weights on the low fat diets were similar (B/6J, 29.5 +/- 0.5 g; A/J, 28.8 +/- 0.6 g; P > 0.05; n = 10). CL316,243 prevented the development of diet-induced obesity in A/J animals, but not in B/6J animals. A/J mice weighed 26.0 +/- 0.5 g at 16 weeks, whereas B/6J animals on the same diet weighed 34.1 +/- 0.8 g (P < 0.00001; n = 10), but food intake was not different between the strains throughout the study. beta-Adrenergic stimulation of adenylyl cyclase in obese B/6J mice was decreased by more than 75% in white adipose tissue and by more than 90% in brown adipose tissue (BAT). In contrast, in fat-fed A/J mice, beta-agonist-stimulated adenylyl cyclase was decreased in white adipose tissue by about 10%, whereas the activity in interscapular BAT was decreased by 50%, indicating significant retention of beta AR-stimulated activity in A/J mice compared to B/6J mice. High fat feeding was associated with decreased expression of beta 3AR and beta 1AR in white adipose tissue of both strains. However, chronic CL316,243 treatment prevented both the obesity and the decline in beta 3AR and beta 1AR messenger RNA levels in all adipose depots from A/J mice, but not B/6J mice. As CL316,243-treated A/J mice, but not B/6J mice, also showed marked uncoupling protein expression in white adipose depots, the ability of chronic CL316,243 treatment to prevent diet-induced obesity is dependent upon the elaboration of functional BAT in these regions.
Insights
High-fat diets can cause obesity by affecting adipocyte adrenergic receptors. A beta 3AR agonist prevented diet-induced obesity in A/J mice by maintaining receptor function and promoting brown fat activity.
Area of Science:
- Metabolic research
- Obesity research
- Pharmacology
Background:
- High-fat diets are linked to obesity development.
- Adipocyte adrenergic receptor (AR) expression and function are adversely affected by fat intake.
- Beta 3AR agonists can reduce adipose tissue and improve thermogenesis.
Purpose of the Study:
- To investigate if chronic high-fat diet supplementation with a beta 3AR agonist (CL316,243) prevents diet-induced obesity.
- To determine if the obesity-preventing effects are sustained with prolonged treatment.
- To explore the impact on adipocyte adrenergic receptor expression and function.
Main Methods:
- C57BL/6J and A/J mice were fed low-fat, high-fat, or high-fat diets with CL316,243.
- Body weight, food intake, and beta-adrenergic stimulation of adenylyl cyclase were measured.
- Expression of beta 3AR, beta 1AR, and uncoupling protein was analyzed in adipose tissues.
Main Results:
- High-fat diet increased weight gain in both mouse strains, with B/6J gaining more than A/J.
- CL316,243 prevented diet-induced obesity in A/J mice but not B/6J mice.
- CL316,243 maintained beta 3AR and beta 1AR expression and stimulated adenylyl cyclase activity in A/J mice, promoting functional brown adipose tissue (BAT).
Conclusions:
- The prevention of diet-induced obesity by chronic CL316,243 treatment depends on the development of functional brown adipose tissue.
- Mouse strain differences in adrenergic receptor regulation influence susceptibility to diet-induced obesity and response to beta 3AR agonists.
- Targeting beta 3AR may be a viable strategy for obesity prevention, contingent on individual metabolic profiles and BAT elaboration.

